In this landscape, it means a claim where the inventive step is explicitly about tailoring monomer structure or composition to achieve a property outcome — such as adhesion, storage stability, low CTE or flexibility — rather than a claim about general polyimide film manufacturing. The search underlying this dataset requires design-intent language (molecular design, monomer design, structure-property optimization or property tailoring) alongside polyimide-specific IPC codes. That combination excludes routine production patents and isolates roughly 79 families where property tuning is the stated point of the invention.

The data shows filings peaking at 7 in 2021 and falling to 2 by the 2022 midpoint, but part of that apparent drop is a publication-lag artefact: patent applications typically publish about 18 months after filing, so the most recent one to two years in any dataset are always undercounted. The genuine signal is that this is a narrow, low-volume niche — it never saw more than single-digit annual filings even at its peak — rather than a fast-growing field experiencing a sudden reversal.

By citation count, the most-referenced record in this corpus is a 1997 filing on polyimide block copolymers and liquid-crystal alignment layers, cited 71 times within this dataset, followed closely by a 1992 fluorinated-polyimide copolymer filing cited 51 times. Both predate most of the recent design-optimization filings and still anchor prior-art searches in block-copolymer and fluorinated-monomer approaches. Any new filing using those design strategies should be checked against this older art specifically, not just against recent competitors.

The core condensation chemistry (C08G) is heavily claimed, appearing in 74 of 79 families, but downstream overlaps are thinner: photolithography-adjacent photodefinable polyimide, adhesive/coverlay formulations, and laminate-level property tailoring for flexible circuits each sit at only 10-12 families. These narrower overlaps carry a shallower prior-art field, though that also means there is less public evidence of what already works, so a novelty search specific to the target application is still necessary before drafting.

The dataset shows filing activity spread across assignees based in Japan, China and the United States without one company filing continuously through the most recent year, and co-assignee filings are rare — only 7 pairs across 79 families, mostly repeated individual inventors rather than corporate joint ventures. That pattern suggests a field with several credible incumbents working independently rather than a single dominant patentee or an active alliance structure.